Phillips-Medisize Opens Global Innovation and Development Office in Denmark

Article

Phillips-Medisize, a Molex company, revealed that it is opening a new Global Innovation and Development (GID) office in Copenhagen, Denmark, to support its plans for growth.

In a Nov. 12, 2019 press release, Phillips-Medisize, a Molex company, revealed that it is opening a new Global Innovation and Development (GID) office in Copenhagen, Denmark, to support its plans for growth.

The GID office will provide the company with the opportunity to grow its advanced injection, wearable devices, and connected health technologies from an easily accessible European hub. Complementing the company’s existing European centers in Struer, Denmark, and Cambridge, United Kingdom, the new office will be located within the Medicon Valley cluster and will benefit from close proximity to universities, hospitals, and global R&D-based pharma and medical device companies.

“The opening of our new Copenhagen GID center represents an exciting opportunity to expand our global footprint by supporting overall growth with closer proximity to current European clients, fortifying our business development efforts and attracting top talent in the region to join our growing team,” said Matt Jennings, CEO and president of Phillips-Medisize in the press release.

Source: Phillips-Medisize

 

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content